Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6346 |
PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6337 |
PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6340 |
MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
SANDOZ RISPERIDONE | 1.0MG | TABLET | Discontinued | 2021-08-19 | 2021-08-19 | 144338 |
SANDOZ RISPERIDONE | 3.0MG | TABLET | Discontinued | 2021-03-22 | 2021-03-22 | 136095 |
TARO-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105101 |
TARO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2019-08-09 | 2019-08-10 | 91284 |
RISPERDAL | 4MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68101 |
RISPERDAL | 2MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68089 |